Global Markets Direct Reports

Sphingosine 1-Phosphate Receptor 5 (Endothelial Differentiation G Protein Coupled Receptor 8 or Sphingosine 1 Phosphate Receptor Edg 8 or S1PR5) - Drugs in Development, 2021

Sphingosine 1-Phosphate Receptor 5 (Endothelial Differentiation G Protein Coupled Receptor 8 or Sphingosine 1 Phosphate Receptor Edg 8 or S1PR5) - Dru...

Published: Apr-2021 | No. of Pages: 35
$ 3000
Ubiquitin Like Modifier Activating Enzyme 1 (Ubiquitin Activating Enzyme E1 or Protein A1S9 or UBA1 or EC 6.3.2.19 or EC 6.2.1.45) - Drugs in Development, 2021

Ubiquitin Like Modifier Activating Enzyme 1 (Ubiquitin Activating Enzyme E1 or Protein A1S9 or UBA1 or EC 6.3.2.19 or EC 6.2.1.45) - Drugs in Developm...

Published: Apr-2021 | No. of Pages: 30
$ 3000
Blood Coagulation (Hematological Disorders) - Drugs in Development, 2021

Blood Coagulation (Hematological Disorders) - Drugs in Development, 2021 Summary Blood Coagulation (Hematological Disorders) - Drugs in Development,...

Published: Apr-2021 | No. of Pages: 40
$ 2000
Uterine Cancer (Oncology) - Drugs in Development, 2021

Uterine Cancer (Oncology) - Drugs in Development, 2021 Summary Uterine Cancer (Oncology) - Drugs in Development, 2021 provides an overview of the Ut...

Published: Apr-2021 | No. of Pages: 110
$ 2000
Metastatic Melanoma (Oncology) - Drugs in Development, 2021

Metastatic Melanoma (Oncology) - Drugs in Development, 2021 Summary Metastatic Melanoma (Oncology) - Drugs in Development, 2021 provides an overview...

Published: Apr-2021 | No. of Pages: 425
$ 2500
Ubiquitin Carboxyl Terminal Hydrolase 7 (Deubiquitinating Enzyme 7 or Ubiquitin Thioesterase 7 or Herpesvirus Associated Ubiquitin Specific Protease or Ubiquitin Specific Processing Protease 7 or USP7 or EC 3.4.19.12) - Drugs in Development, 2021

Ubiquitin Carboxyl Terminal Hydrolase 7 (Deubiquitinating Enzyme 7 or Ubiquitin Thioesterase 7 or Herpesvirus Associated Ubiquitin Specific Protease o...

Published: Apr-2021 | No. of Pages: 35
$ 3000
Utrophin (Dystrophin Related Protein 1 or DRP1 or UTRN) - Drugs in Development, 2021

Utrophin (Dystrophin Related Protein 1 or DRP1 or UTRN) - Drugs in Development, 2021 Summary Utrophin (Dystrophin Related Protein 1 or DRP1 or UTRN)...

Published: Apr-2021 | No. of Pages: 30
$ 3000
Lupus Erythematosus (Immunology) - Drugs in Development, 2021

Lupus Erythematosus (Immunology) - Drugs in Development, 2021 Summary Lupus Erythematosus (Immunology) - Drugs in Development, 2021 provides an over...

Published: Apr-2021 | No. of Pages: 40
$ 2000
Atrophic Vaginitis (Vaginal Atrophy/Vulvovaginal Atrophy/Urogenital Atrophy) (Women's Health) - Drugs in Development, 2021

Atrophic Vaginitis (Vaginal Atrophy/Vulvovaginal Atrophy/Urogenital Atrophy) (Women's Health) - Drugs in Development, 2021 Summary Atrophic Vaginiti...

Published: Apr-2021 | No. of Pages: 35
$ 2000
Metastatic Ovarian Cancer (Oncology) - Drugs in Development, 2021

Metastatic Ovarian Cancer (Oncology) - Drugs in Development, 2021 Summary Metastatic Ovarian Cancer (Oncology) - Drugs in Development, 2021 provides...

Published: Apr-2021 | No. of Pages: 115
$ 2000
Acquired (Autoimmune) Hemolytic Anemia (Hematological Disorders) - Drugs in Development, 2021

Acquired (Autoimmune) Hemolytic Anemia (Hematological Disorders) - Drugs in Development, 2021 Summary Acquired (Autoimmune) Hemolytic Anemia (Hemato...

Published: Apr-2021 | No. of Pages: 50
$ 2000
Usherin (Usher Syndrome Type 2A Protein or USH2A) - Drugs in Development, 2021

Usherin (Usher Syndrome Type 2A Protein or USH2A) - Drugs in Development, 2021 Summary Usherin (Usher Syndrome Type 2A Protein or USH2A) - Drugs in ...

Published: Apr-2021 | No. of Pages: 35
$ 3000
Vascular Endothelial Growth Factor C (Flt4 Ligand or Vascular Endothelial Growth Factor Related Protein or VEGFC) - Drugs in Development, 2021

Vascular Endothelial Growth Factor C (Flt4 Ligand or Vascular Endothelial Growth Factor Related Protein or VEGFC) - Drugs in Development, 2021 Summar...

Published: Apr-2021 | No. of Pages: 30
$ 3000
Facioscapulohumeral Muscular Dystrophy (FSHD) (Musculoskeletal Disorders) - Drugs in Development, 2021

Facioscapulohumeral Muscular Dystrophy (FSHD) (Musculoskeletal Disorders) - Drugs in Development, 2021 Summary Facioscapulohumeral Muscular Dystroph...

Published: Apr-2021 | No. of Pages: 40
$ 2000
Varicella Zoster (HHV-3) Infections (Infectious Disease) - Drugs in Development, 2021

Varicella Zoster (HHV-3) Infections (Infectious Disease) - Drugs in Development, 2021 Summary Varicella Zoster (HHV-3) Infections (Infectious Diseas...

Published: Apr-2021 | No. of Pages: 35
$ 2000
Metastatic Pancreatic Cancer (Oncology) - Drugs in Development, 2021

Metastatic Pancreatic Cancer (Oncology) - Drugs in Development, 2021 Summary Metastatic Pancreatic Cancer (Oncology) - Drugs in Development, 2021 pr...

Published: Apr-2021 | No. of Pages: 160
$ 2000
Acute Coronary Syndrome (Cardiovascular) - Drugs in Development, 2021

Acute Coronary Syndrome (Cardiovascular) - Drugs in Development, 2021 Summary Acute Coronary Syndrome (Cardiovascular) - Drugs in Development, 2021 ...

Published: Apr-2021 | No. of Pages: 50
$ 2000
Voltage Dependent T Type Calcium Channel Subunit Alpha 1H (Voltage Gated Calcium Channel Subunit Alpha Cav3.2 or CACNA1H) - Drugs in Development, 2021

Voltage Dependent T Type Calcium Channel Subunit Alpha 1H (Voltage Gated Calcium Channel Subunit Alpha Cav3.2 or CACNA1H) - Drugs in Development, 2021...

Published: Apr-2021 | No. of Pages: 35
$ 3000
Vascular Endothelial Growth Factor D (c Fos Induced Growth Factor or VEGFD or FIGF) - Drugs in Development, 2021

Vascular Endothelial Growth Factor D (c Fos Induced Growth Factor or VEGFD or FIGF) - Drugs in Development, 2021 Summary Vascular Endothelial Growth...

Published: Apr-2021 | No. of Pages: 30
$ 3000
Gynecological Cancer (Oncology) - Drugs in Development, 2021

Gynecological Cancer (Oncology) - Drugs in Development, 2021 Summary Gynecological Cancer (Oncology) - Drugs in Development, 2021 provides an overvi...

Published: Apr-2021 | No. of Pages: 40
$ 2000